{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:38Z","timestamp":1790799998862,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ijcard.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T21:10:11Z","timestamp":1549746611000},"page":"198-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies"],"prefix":"10.1016","volume":"286","author":[{"given":"Giulia","family":"Renda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-3968","authenticated-orcid":false,"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Marthe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta M.","family":"Siller-Matula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Hylek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-574X","authenticated-orcid":false,"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.02.004_bb0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1067\/mhl.2001.118764","article-title":"Sex differences and the effects of sex hormones on hemostasis and vascular reactivity","volume":"30","author":"Schwertz","year":"2001","journal-title":"Heart Lung"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0010","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0015","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.106.620815","article-title":"Sex differences in major bleeding with glycoprotein IIb\/IIIa inhibitors: results from the CRUSADE (can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC\/AHA guidelines) initiative","volume":"114","author":"Alexander","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0025","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","article-title":"Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries","volume":"373","author":"Kotseva","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0035","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinternmed.2009.318","article-title":"Sex-specific trends in midlife coronary heart disease risk and prevalence","volume":"169","author":"Towfighi","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/ATVBAHA.108.179788","article-title":"Thrombosis and antithrombotic therapy in women","volume":"29","author":"Bailey","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.RES.81.5.885","article-title":"17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization","volume":"81","author":"Caulin-Glaser","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0050","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1210\/jc.2005-0591","article-title":"Hemostatic factors and estrogen during the menopausal transition","volume":"90","author":"Sowers","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1507\/endocrj.48.33","article-title":"Sex difference in platelet aggregation detected by new aggregometry using light scattering","volume":"48","author":"Haque","year":"2001","journal-title":"Endocr. J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/MBC.0b013e32835824b3","article-title":"Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy","volume":"23","author":"Bobbert","year":"2012","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12471-011-0189-y","article-title":"Effect of gender difference on platelet reactivity","volume":"19","author":"Breet","year":"2011","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/gme.0b013e31825ebafd","article-title":"Platelet reactivity and thrombogenicity in postmenopausal women","volume":"20","author":"Singla","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000441-199504000-00003","article-title":"Sex differences in platelet adherence to subendothelium: relationship to platelet function tests and hematologic variables","volume":"309","author":"Lawrence","year":"1995","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0080","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.295.12.1420","article-title":"Sex differences in platelet reactivity and response to low-dose aspirin therapy","volume":"295","author":"Becker","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0085","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1055\/s-0038-1656045","article-title":"Gender differences in platelet GPIIb-IIIa activation","volume":"77","author":"Faraday","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0038-1650033","article-title":"A sex difference in the bleeding time","volume":"43","author":"Bain","year":"1980","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0030-1270074","article-title":"Hormonal influences on hemostasis in women","volume":"37","author":"Trigg","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2019.02.004_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697130903006365","article-title":"The hemostatic system through aging and menopause","volume":"12","author":"Bucciarelli","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GME.0000000000000296","article-title":"Hormone therapy and hemostasis among postmenopausal women: a review","volume":"21","author":"Canonico","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1521-690X(02)00079-9","article-title":"Hormone therapy and venous thromboembolism","volume":"17","author":"Peverill","year":"2003","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1440-1681.2007.04685.x","article-title":"Ageing, oestrogen, platelets and thrombotic risk","volume":"34","author":"Miller","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCINTERVENTIONS.109.860494","article-title":"Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry","volume":"2","author":"Ahmed","year":"2009","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0125","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0130","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2011.09.075","article-title":"Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease","volume":"59","author":"Wang","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0140","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/eurheartj\/ehr423","article-title":"Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects","volume":"32","author":"Dorresteijn","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0145","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"A.S.C. Group","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0155","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0160","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0165","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0170","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0175","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2009.05.074","article-title":"The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis","volume":"54","author":"Berger","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0180","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0185","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0195","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0200","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/STROKEAHA.108.542894","article-title":"Gender differences in stroke incidence and poststroke disability in the Framingham heart study","volume":"40","author":"Petrea","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0215","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group","volume":"321","author":"Hass","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0225","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"E.S. Group","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0230","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000076962","article-title":"Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data","volume":"17","author":"Diener","year":"2004","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000092922","article-title":"Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage","volume":"22","author":"Shinohara","year":"2006","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0245","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1474-4422(10)70198-8","article-title":"Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial","volume":"9","author":"Shinohara","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0250","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2016.12.038","article-title":"Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease","volume":"69","author":"Renda","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0255","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0265","first-page":"385","article-title":"Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms","volume":"111","author":"Cove","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0270","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2013.10.035","article-title":"Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants","volume":"113","author":"Pancholy","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0280","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2012.04853.x","article-title":"Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study","volume":"10","author":"Mikkelsen","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0285","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.ijcard.2019.02.004_bb0290","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/europace\/euy215","article-title":"Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling","volume":"21","author":"Odening","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014579","article-title":"Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry","volume":"7","author":"Camm","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0300","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1161\/CIRCOUTCOMES.114.001556","article-title":"Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation","volume":"8","author":"Lip","year":"2015","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euy067","article-title":"Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society","volume":"20","author":"Linde","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0310","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2018.07.044","article-title":"Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients","volume":"269","author":"Marzona","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0315","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.phrs.2017.01.004","article-title":"Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): a systematic review and meta-analysis on gender differences","volume":"117","author":"Proietti","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jacc.2018.04.066","article-title":"Sex-based differences in outcomes of oral anticoagulation in patients with atrial fibrillation","volume":"72","author":"Law","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jacc.2018.05.015","article-title":"Sex implications in the response to anticoagulant therapy in atrial fibrillation","volume":"72","author":"Renda","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0335","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0340","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0345","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0350","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8632","article-title":"Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study","volume":"346","author":"Henriksson","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0355","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","article-title":"Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study","volume":"10","author":"Sweetland","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0360","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0365","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0370","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.1994.00420080053005","article-title":"The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly","volume":"154","author":"Kniffin","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cncr.20347","article-title":"The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review","volume":"101","author":"Deitcher","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0380","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","article-title":"Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis","volume":"368","author":"McRae","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0385","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0035-1564042","article-title":"Gender difference in efficacy and safety of nonvitamin K antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation or venous thromboembolism: a systematic review and a meta-analysis of the literature","volume":"41","author":"Dentali","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0390","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1016\/S2352-3026(16)30111-9","article-title":"Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series","volume":"3","author":"Beyer-Westendorf","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0395","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0400","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.105.576751","article-title":"Acute myocardial infarction in pregnancy: a United States population-based study","volume":"113","author":"James","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2008.03.049","article-title":"Acute myocardial infarction associated with pregnancy","volume":"52","author":"Roth","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0410","first-page":"90","article-title":"Platelets in pregnancy","volume":"5","author":"Juan","year":"2011","journal-title":"J. Prenat. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0415","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0030-1270339","article-title":"Platelet function in pre-eclampsia","volume":"37","author":"Kazmi","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0420","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu279","article-title":"Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A \u2018state-of-the-art\u2019 paper","volume":"35","author":"Patti","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0425","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccl.2012.04.007","article-title":"Cardiovascular drugs in pregnancy","volume":"30","author":"Frishman","year":"2012","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0301-2115(02)00429-3","article-title":"Nitric oxide donors: effects on fetoplacental blood flow","volume":"115","author":"Kahler","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0435","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0440","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0445","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0450","series-title":"Drugs in Pregnancy and Lactation","author":"Briggs","year":"2009"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0455","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2169\/internalmedicine.50.5294","article-title":"Clopidogrel treatment during pregnancy: a case report and a review of literature","volume":"50","author":"De Santis","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccl.2012.05.003","article-title":"Anticoagulation in pregnancy","volume":"30","author":"Goland","year":"2012","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0465","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2000.tb11696.x","article-title":"Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves","volume":"107","author":"Sadler","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0470","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0475","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2008.10.014","volume":"52","author":"Bonow","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0485","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0490","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/bjh.13147","article-title":"The use of fondaparinux in pregnancy","volume":"168","author":"Elsaigh","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0495","author":"eMC"},{"key":"10.1016\/j.ijcard.2019.02.004_bb0500","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1160\/th14-04-0393","article-title":"Oral anticoagulation with rivaroxaban during pregnancy: a case report","volume":"112","author":"Konigsbrugge","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.02.004_bb0505","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1753495X15621814","article-title":"Unplanned pregnancy on a direct oral anticoagulant (Rivaroxaban): a warning","volume":"9","author":"Myers","year":"2016","journal-title":"Obstet. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318351209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318351209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:44:16Z","timestamp":1759092256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318351209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":101,"alternative-id":["S0167527318351209"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.02.004","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}